Company Profile
Ascentawits Pharmaceuticals, Ltd is a clinical stage biotech company, we are pioneer in developing selectively intracellularly activated SMDC for unmet medical needs: Pancreatic cancer, HCC, ICC et al.
Corporate Speaker
Dr. Jianxin Duan
Chairman, CEO & Founder
Dr. Jianxin Duan, Chairman, CEO and Founder of Ascentawits Pharmaceuticals, Ltd. Dr. Duan got his Ph.D. from University of Florida and has focused on SMDC research for over 20 years, he is very experienced in anticancer drug research. Dr. Duan has numerous patent applications granted and published more than 40 paper in peer reviewed Journals.
Company Website